Neuhaus, T., J. Luyken, and S. Stier. “Discontinuation of the Tyrosine Kinase Inhibitor Sunitinib in Patients With Metastatic Renal Cell Carcinoma: A Case Series”. Urology Journal, vol. 11, no. 2, May 2014, pp. 1494-8, doi:10.22037/uj.v11i2.1672.